1Lip GYH.Thromboprophylaxis for atrial fibrillation[J].Lancet,1999,353:426.
2Yamaguchi T.Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation-a multicenter,prospective,randomized trial[J].Stroke,2000,31:817-821.
3Petersen P,Grind M,Adler J.SPORTIF Ⅱ Investigators.Ximelagatran versus warfarin for stroke prevention in patients with nonvalvular atrial fibrillation.SPORTIFⅡ:A dose guiding,tolerability,and safety study[J].J Am Coll Cardiol,2003,41:1445-1451.
4Executive Steering Committee on behalf of the SPORTIF Ⅲ investigators.Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF Ⅲ):Randomized controlled trial[J].Lancet,2003,362:1691-1698.
5Halperin JL,and the Executive Steering Committee,on behalf of the SPORTIF Ⅲ and Ⅴ Study Investigators.Ximelagatran compared with warfarin for prevention of thromboembolism in patients with nonvalvular atrial fibrillation:rationale,objectives,and design of a pair of clinical studies and baseline patient characteristics (SPORTIF Ⅲ and V)[J].Am Heart J,2003,146:431-438.
6The Stroke Prevention in A trial Fibrillation Investigators.Stroke prevention in atrial fibrillation study:Final results[J].Circulation,1991,84:527-539.
7Adjusted-dose warfarin versus low-intensity,fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation:Stroke Prevention in Atrial Fibrillation III randomized clinical trial[J].Lancet,1996,348:633-638.
8Yusuf S,Zhao F,Mehta SR,et al.Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation[J].N Engl J Med,2001,345:494-502.
9John G.F,Alison P.C,Mike L,et al.Clinical trials update from the European Society of Cardiology meeting 2005:CARE-HF extension study,ESSENTIAL,CIBIS-III,S-ICD,ISSUE-2,STRIDE-2,SOFA,IMAGINE,PREAMI,SIRIUS-II and ACTIVE.
10Wyse DG,Waldo AL,et al.A comparison of rate control and rhythm control in patients with atrial fibrillation[J].N Engl J Med,2002,347:1825-1833.
